The launch of Mathys & Squire Consulting follows the exciting acquisition of leading IP consulting firm Coller IP in 2017, when Mathys & Squire sought to develop its IP strategy and… read more…
Like many patent offices, the EPO does not allow applicants to claim methods for treatment of the human or animal body by surgery or therapy (Article 53(c) EPC) Such exclusions are historically… read more…
In this article for PCR, Mathys & Squire Partner Andrew White and Technical Assistant Conor McGuinness, look at the patentability of computer games in Europe and the UK and address the common… read more…
A new edition of the EPO Guidelines for Examination (‘the guidelines’) came into force on 1 March 2021 Relevant to life sciences, this edition includes a new subsection detailing EPO practice… read more…
Further to our article in July 2020 on the EPO Enlarged Board of Appeal’s hearing in G1/19, the Enlarged Board has now published its long-awaited decision relating to the patentability of… read more…
In this article for Intellectual Property Magazine, Mathys & Squire associate Max Thoma and technical assistant Oliver Parish consider the importance of drawings in determining the scope of a… read more…
Women throughout history continue to make their mark creating innovations and discoveries that impact our lives today To celebrate International Women’s Day 2021, we reflect on inspiring female… read more…
World Trademark Review has featured Mathys & Squire in its latest edition of the WTR 1000 directory, highlighting the firm’s “professional, responsive and wide-ranging service” and its… read more…
In a number of recent cases, patent offices have refused to allow artificial intelligence and machine learning systems to be credited as inventors in patent applications How are patent systems to… read more…